Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Authors
Keywords
Type 2 diabetes, Metformin, Atorvastatin, Simvastatin, Combination therapy, Dyslipidemia, Glucose metabolism, Lipid metabolism
Journal
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-30
DOI
10.1186/s12933-018-0738-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats
- (2018) Tariq Jamal Khan et al. Scientific Reports
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis
- (2017) Shaohua Wang et al. Scientific Reports
- Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
- (2017) Jose A. Caparrós-Martín et al. Microbiome
- Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state
- (2017) Philipp Schommers et al. Molecular Metabolism
- Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
- (2017) Olga Gruzdeva et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia
- (2016) Andrew W. Dake et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Managing dyslipidaemia in type 2 diabetes mellitus
- (2016) Auryan Szalat et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes
- (2016) Zhaoli Ling et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of hepatic energy metabolism by the nuclear receptor PXR
- (2016) Jukka Hakkola et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
- (2016) Hannah R. Bridges et al. BMC BIOLOGY
- Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
- (2016) Martin Bødtker Mortensen et al. Cardiovascular Diabetology
- Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes
- (2016) Peter Godsk Jørgensen et al. Cardiovascular Diabetology
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells
- (2016) Jing Wang et al. CELLULAR SIGNALLING
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Gut microbiome and lipid metabolism
- (2016) Zheng Wang et al. CURRENT OPINION IN LIPIDOLOGY
- Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
- (2016) Thomas A. Lutz et al. CURRENT OPINION IN LIPIDOLOGY
- Diabetic dyslipidaemia
- (2016) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency
- (2016) Jonas B. Jensen et al. DIABETES
- Metformin Is Associated With Higher Relative Abundance of Mucin-DegradingAkkermansia muciniphilaand Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
- (2016) Jacobo de la Cuesta-Zuluaga et al. DIABETES CARE
- Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
- (2016) David Preiss et al. DIABETES OBESITY & METABOLISM
- Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes
- (2016) Hui Fan et al. Diabetes Technology & Therapeutics
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response
- (2016) Annalisa Natalicchio et al. ENDOCRINOLOGY
- Atorvastatin Plus Metformin Confer Additive Benefits on Subjects with Dyslipidemia and Overweight/Obese via Reducing ROCK2 Concentration
- (2016) Z. Hao et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Will delayed release metformin provide better management of diabetes type 2?
- (2016) André J. Scheen EXPERT OPINION ON PHARMACOTHERAPY
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses
- (2016) Ulrich Rohde et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
- (2016) L. C. Gormsen et al. JOURNAL OF NUCLEAR MEDICINE
- Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
- (2016) William R. Proctor et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
- (2016) Fei Luo et al. Lipids in Health and Disease
- Atorvastatin inhibits insulin synthesis by inhibiting the Ras/Raf/ERK/CREB pathway in INS-1 cells
- (2016) Hongxi Sun et al. MEDICINE
- Pharmacometabolomic signature links simvastatin therapy and insulin resistance
- (2016) Mona Elbadawi-Sidhu et al. Metabolomics
- Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery
- (2016) Kaixin Zhou et al. Nature Reviews Endocrinology
- Effect of metformin on global gene expression in liver of KKAy mice
- (2016) Zhi-Qin Liu et al. Pharmacological Reports
- Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System
- (2016) Ingmar Lundquist et al. PLoS One
- Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells
- (2016) Melissa F. Brereton et al. Nature Communications
- Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation
- (2016) Tien-Jyun Chang et al. Scientific Reports
- Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes
- (2016) Adam R. Konopka et al. Cell Reports
- Early Effects of Treatment Low-Dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
- (2016) Olga Gruzdeva et al. Frontiers in Pharmacology
- Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
- (2016) Valentina Scattolini et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures
- (2016) Valentina Scattolini et al. Diabetes Therapy
- Diabetes Dyslipidemia
- (2016) Jonathan D. Schofield et al. Diabetes Therapy
- The Enigma of Glucose and Lipid Metabolism
- (2016) Neha J. Pagidipati et al. JAMA Cardiology
- The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin
- (2016) Zahra Kashi et al. PLoS One
- New Insights into the Regulation of Chylomicron Production
- (2015) Satya Dash et al. Annual Review of Nutrition
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome
- (2015) Marcello Arca ATHEROSCLEROSIS SUPPLEMENTS
- Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity
- (2015) Chao Zhang et al. Cardiovascular Diabetology
- Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition
- (2015) Tom J.J. Schirris et al. Cell Metabolism
- Metformin Action: Concentrations Matter
- (2015) Ling He et al. Cell Metabolism
- Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial
- (2015) Kumiko Tanaka et al. CLINICAL DRUG INVESTIGATION
- Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism
- (2015) U Anyanwagu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism
- (2015) Changting Xiao et al. DIABETES
- Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858–1867
- (2015) David P. Sonne et al. DIABETES CARE
- Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
- (2015) Tao Xu et al. DIABETES CARE
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
- (2015) Henna Cederberg et al. DIABETOLOGIA
- Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin
- (2015) Ju-Hee Oh et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
- (2015) Ele Ferrannini et al. EUROPEAN HEART JOURNAL
- Akkermansia muciniphilaand improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
- (2015) Maria Carlota Dao et al. GUT
- Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes
- (2015) Tushar P. Patel et al. HEART FAILURE REVIEWS
- AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms
- (2015) Yu-Lu Dai et al. International Journal of Biological Sciences
- Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro
- (2015) Yun-Xi Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Protonation–deprotonation and structural dynamics of antidiabetic drug metformin
- (2015) Belén Hernández et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- The expression of genes involved in jejunal lipogenesis and lipoprotein synthesis is altered in morbidly obese subjects with insulin resistance
- (2015) Carolina Gutierrez-Repiso et al. LABORATORY INVESTIGATION
- Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
- (2015) Mustafa Kinaan et al. MEDICAL PRINCIPLES AND PRACTICE
- Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?
- (2015) Julian Halcox et al. Metabolic Syndrome and Related Disorders
- Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)
- (2015) Xiaomin Liang et al. MOLECULAR PHARMACEUTICS
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats
- (2015) Frank A Duca et al. NATURE MEDICINE
- Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
- (2015) Darleen A. Sandoval et al. PHYSIOLOGICAL REVIEWS
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)
- (2015) Andre Madsen et al. Scientific Reports
- Statin-activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis
- (2015) Saki Gotoh et al. Scientific Reports
- An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials
- (2015) J. Sun et al. BMJ Open
- A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health
- (2015) Maud Soty et al. Molecular Metabolism
- Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
- (2015) Klaus G. Parhofer Diabetes & Metabolism Journal
- Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells
- (2015) Nagendra Yaluri et al. PLoS One
- Haemostatic Effects of Metformin in Simvastatin-Treated Volunteers with Impaired Fasting Glucose
- (2014) Robert Krysiak et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?
- (2014) Joseph A. Baur et al. Cell Metabolism
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
- (2014) Tanja Dujic et al. DIABETES
- The Oral Minimal Model Method
- (2014) C. Cobelli et al. DIABETES
- Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study
- (2014) Giovanni Corrao et al. DIABETES CARE
- Intestinal glucose metabolism revisited
- (2014) Gilles Mithieux et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- AMPK in the Small Intestine in Normal and Pathophysiological Conditions
- (2014) Elodie Harmel et al. ENDOCRINOLOGY
- Statin therapy and related risk of new-onset type 2 diabetes mellitus
- (2014) Massimiliano Ruscica et al. European Journal of Internal Medicine
- The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial
- (2014) R. Neil A. Black et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades
- (2014) Alan F. Hofmann et al. JOURNAL OF LIPID RESEARCH
- Diabetic dyslipidemia
- (2014) Liya Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults
- (2014) Takehiro Sugiyama et al. JAMA Internal Medicine
- Lipids and lipid management in diabetes
- (2013) Mamta Jaiswal et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin inhibits macrophage cholesterol biosynthesis rate: Possible role for metformin-induced oxidative stress
- (2013) Marie Koren-Gluzer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diabetic Dyslipidemia: From Evolving Pathophysiological Insight to Emerging Therapeutic Targets
- (2013) Dominic S. Ng Canadian Journal of Diabetes
- Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations
- (2013) Kirti Kandhwal et al. CLINICAL DRUG INVESTIGATION
- Restoring Insulin Secretion (RISE): Design of Studies of β-Cell Preservation in Prediabetes and Early Type 2 Diabetes Across the Life Span
- (2013) DIABETES CARE
- Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
- (2013) Joe M. Chehade et al. DRUGS
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
- (2013) Francesco Paneni et al. EUROPEAN HEART JOURNAL
- AMPK, insulin resistance, and the metabolic syndrome
- (2013) Neil B. Ruderman et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
- (2013) Mi-Hyun Kim et al. JOURNAL OF ENDOCRINOLOGY
- Genetic Variants of the Fatty Acid Desaturase Gene Cluster Are Associated with Plasma LDL Cholesterol Levels in Japanese Males
- (2013) Yasuko SONE et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose
- (2012) Robert Krysiak et al. ATHEROSCLEROSIS
- Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
- (2012) Marcello Arca et al. Current Vascular Pharmacology
- Pancreatic β-cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetes
- (2012) S. J. Muhammed et al. DIABETES OBESITY & METABOLISM
- Metformin Stimulates FGF21 Expression in Primary Hepatocytes
- (2012) Eva B. Nygaard et al. Experimental Diabetes Research
- Overview of metformin: special focus on metformin extended release
- (2012) Shamsa Ali et al. EXPERT OPINION ON PHARMACOTHERAPY
- AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases
- (2012) Rai Ajit K. Srivastava et al. JOURNAL OF LIPID RESEARCH
- The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose
- (2012) Robert Krysiak et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity
- (2011) K. Mezghenna et al. DIABETOLOGIA
- Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study
- (2010) Dimitris Tousoulis et al. CLINICAL THERAPEUTICS
- Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic -Cell Dysfunction
- (2010) M. Vergeer et al. DIABETES CARE
- Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
- (2010) Arpita Chakraborty et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia
- (2010) P. Matafome et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Electrodeless, accurate pH determination in highly basic media using a new set of 1H NMR pH indicators
- (2010) Gábor Orgován et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- (2009) B. Viollet et al. Acta Physiologica
- Regulation Mechanisms and Signaling Pathways of Autophagy
- (2009) Congcong He et al. Annual Review of Genetics
- Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
- (2009) E. Bosi DIABETES OBESITY & METABOLISM
- Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus
- (2009) Dimitris Tousoulis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of High-Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Nonobese Type 2 Diabetic Patients
- (2008) J. Szendroedi et al. DIABETES CARE
- Metformin and the intestine
- (2008) C. J. Bailey et al. DIABETOLOGIA
- Effects of Atorvastatin and Pravastatin on Signal Transduction Related to Glucose Uptake in 3T3L1 Adipocytes
- (2008) Akira Takaguri et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started